Tech: Amgen scientists work at the company’s Thousand Oaks headquarters. Thousand Oaks-based pharma giant Amgen Inc. said it would lay off approximately 450 employees, or nearly 2% of its workforce, ...

In January, Amgen laid off about 300 employees as part of organizational changes, which "mainly" impacted the U.S.-based commercial team. "We made these changes to better manage against industry ...

Amgen, a drugmaker based in Thousand Oaks, Calif., will lay off 450 people — 2 percent of its workforce — with many separations occurring by May 26.

Amgen is laying off more workers in Ventura County. The bio-pharmaceutical giant said March 16 that it will eliminate about 450 jobs, or less than 2% of its global workforce. That’s on top of 305 cuts ...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Amgen To Contact Him Directly To Discuss Their Options New York, New York ...

Amgen Inc. (NASDAQ: AMGN) is expected to report quarterly earnings at $4 per share on revenue of $6.26 billion, analysts say.

The Supreme Court appeared to struggle Monday over Amgen Inc.'s arguments in a dispute with Sanofi S.A. that two canceled ...

March 27 (Reuters) - Amgen Inc's (AMGN.O) battle with Sanofi (SASY.PA) and Regeneron (REGN.O) at the U.S. Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ...

On Monday the Supreme Court will hear oral arguments in Amgen v. Sanofi, a case with immense potential consequences for scientific innovation. If the high court upends settled patent law by ...

In the latest trading session, Amgen (AMGN) closed at $238.48, marking a +0.73% move from the previous day. The stock outpaced the S&P 500's daily loss of 0.16%. Meanwhile, the Dow lost 0.12% ...

Amgen reported solid results for fiscal 2022 with the bottom line growing in the double digits. The company recently announced the acquisition of Horizon Therapeutics and while the acquisition ...